CIK 0001635077
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Aclarion, Inc.
Sign in to watch- Ticker
- ACON
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 473324725
- Phone
- +1 833-275-2266
- Business address
- 8181 ARISTA PLACE, STE 100, BROOMFIELD, CO, 80021
- Former names
- Nocimed, Inc.
Securities
- ACON Common Stock Nasdaq
- ACONW Warrant Nasdaq
- Open-market buys, last 90 days
- $4,879
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$4,879. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-13 | Neal David K Director | Purchase | +7,500 | $2.40 | $18K | 30,002 |
| 2026-06-11 | Neal David K Director | Grant or award | +20,000 | 22,502 | ||
| 2026-05-11 | Neal David K Director | Purchase | +2,500 | $3.10 | $8K | 2,502 |
| 2022-12-02 | Neal David K Director | Other acquisition | +152,128 | 186,528 | ||
| 2022-12-02 | Neal David K Director | Other disposition | −152,128 | 186,528 | ||
| 2022-04-21 | Neal David K Director | Purchase | +34,400 | $4.35 | $150K | 34,400 |
| 2022-04-21 | Neal David K Director | Purchase · Warrants for Common Stock (right to buy) | +34,400 | 104,681 |
Page 1 of 1 · 7 trades